Stock data

昱展新藥 (6785)

昱展新藥 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$0.00M. EPS over the last four quarters totals -NT$1.07.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 昱展新藥 in Insightr